STAT3 and cancer: Although better understanding of MDSC biology is needed to open new windows of therapeutic opportunities, given that the STAT3 signaling pathway is a central regulator in tumorigenesis and the generation of M-MDSCs, there is huge potential in new cancer chemotherapies targeting the STAT3 pathway.